U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07132684) titled 'Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients' on Aug. 13.
Brief Summary: This study is a multicenter, randomized, controlled phase III clinical trial aimed at comparing the efficacy of two induction chemotherapy regimens-VA (Venetoclax + Azacitidine) and D/IA (Daunorubicin/Idarubicin + Cytarabine)-in elderly patients (aged 60-75) with acute myeloid leukemia (AML) who are fit for intensive chemotherapy.
Study Start Date: Aug. 30
Study Type: INTERVENTIONAL
Condition:
AML, Adult
Intervention:
DRUG: Daunorubicin/Idarubicin
Daunorubicin/Idarubicin is used in Induction Therapy and Main...